The prestigious ‘61st Indian Pharmaceutical Congress’ (IPC 2009) will commence in Ahmedabad from Friday, December 11, 2009 at the Nirma University, Ahmedabad. The mega event has attracted interest of the stakeholders in such a way that for the first time in the history of the industry, live web-casting of the inaugural session and other important events of the IPC will be made. As the industry is gearing up for enhancing its presence in the global markets, the discussion during the 61st IPC will revolve around the central theme of “Pharma Vision 2020 – Building Trust in Safety and Efficacy of Medicines”.
The three-day event, being organized in the city after a gap of 23 years, is expected to see participation of more than 8,000 delegates including the CEO’s and top executives of the pharmaceutical industry, officers from regulatory bodies, pharmacist from trade and profession, research and development personnel, pharmaceutical consultants, hospital administration, top officials of central and state agencies, academicians and students from medical and pharmacy colleges. Considering the growing importance of Indian pharma industry, more than 25 foreign speakers will also attend the summit.
Indian Pharmaceutical Congress is organized every year by the Indian Pharmaceutical Congress Association (IPCA), which is federation of five professional bodies namely Indian Pharmaceutical Association (IPA), Indian Pharmaceutical Graduates’ Association (IPGA), Indian Hospital Pharmacists’ Association (IHPA), Association of Pharmaceutical Teachers’ of India (APTI) and All India Drugs Control Officers’ Confederation (AIDCOC).
An exhibition of the pharmaceutical industry – “PHARMAceutical EXPO 2009” will be a major attraction of the event, which will provide a platform to the participating companies to display their products and services and also help the top executives including decision makers in updating their knowledge about the latest bulk drugs, machinery, packaging materials, ancillary equipment and services available in the market. The exhibition is being organized by the Federation of Indian Chambers of Commerce & Industry (FICCI), while Express Pharma has been roped in as the exclusive official media partner for the event.
Ahmedabad has been selected as a venue for the event with a strategic consideration, as the pharmaceutical sector is one of the Gujarat’s most developed and cost competitive sector with presence of many established players. Gujarat is known as the hub of Indian pharmaceutical industry with around 3,245 manufacturing licenses. The state produces maximum number of dosages within the country and contributes 42% to industry’s total turnover and 22% to the export. Gujarat is also known as the export hub of India with companies from the state having presence in more than 200 overseas markets.
Ahmedabad is also an industry base for sectors like chemical and pharmaceutical. Several business conglomerates such as Reliance Industries, Nirma Group of Industries, Claris Life Sciences, Cadila Pharmaceuticals, Zydus Cadila Healthcare Limited, Nova Pharmaceutical, Vadilal industries, Core healthcare, AIA Engineering, Dishman Pharmaceuticals & Chemical already have operations in the city.
In view of this, Ahmedabad offers enormous potential for industries such as lab equipment & machinery manufactures, pharma ingredients makers, packaging materials units, water treatment and waste management service providers and pharma software companies.
The focus of 61st IPC will be consumer centric and efforts will be made to involve consumer organizations, other social organizations and professionals in the growth of the industry. As a part of these efforts, an initiative called ‘Project Concern’ was also launched on August 8, 2009 in Thane having following objectives:-
• Improving healthcare delivery system through intervention of the pharmacist.
• Scientifically establish the value addition made by intervention of the pharmacist.
• To focus on preventive healthcare
• To project pharmacists as family pharmacist.
60 pharmacists from Mumbai, Thane, Raigad, Pune, Kolhapur and Aurangabad are participating in the ‘Project Concern’ and the outcome of this project will be presented during the IPC 2009. The same will be replicated at national level also.
The Scientific Services Committee has also made arrangement for presentation on original scientific work during the event. Various researchers will make presentation on subjects such as pharmaceutical technology, medicinal chemistry, pharmacognosy, indigenous drugs, herbal formulations & phytochemistry, pharmacology, toxicology, clinical Researrch & pharmacovigilance and so on.
The Indian pharmaceutical industry, valued at approximately US$ 12 billion including exports, is ranked 4th in terms of volume and 13th in terms of value in the world. Over the past few years, foreign companies have been showing great interest in this industry because of its strong technological base, low cost productions, low R&D costs innovative scientific manpower and strength of national laboratories. With a domestic growth rate of 8.5% and an exports growth rate of 18% per annum, the Indian Pharmaceutical Industry is one of the fastest growing industries, encompassing unlimited opportunities.
The tremendous growth in Indian Pharmaceutical Industry has also led to exponential growth in the associated industries like lab equipment, machinery manufacturers, pharma ingredients, packaging material, water treatment & waste management, pharma software companies etc.